BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34735415)

  • 21. Best Practices for
    Tade FI; Sajdak RA; Gabriel M; Wagner RH; Savir-Baruch B
    J Nucl Med Technol; 2019 Dec; 47(4):282-287. PubMed ID: 31182661
    [No Abstract]   [Full Text] [Related]  

  • 22. Multifocal Meningiomas Mimicking Dural-Based Intracranial Metastases at 18F-Fluciclovine PET/CT.
    Manganaro MS; Millet JD; Manganaro MS
    Clin Nucl Med; 2019 Jul; 44(7):594-595. PubMed ID: 31107759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial.
    Schreibmann E; Schuster DM; Rossi PJ; Shelton J; Cooper S; Jani AB
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):206-13. PubMed ID: 27511856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-Fluciclovine Uptake in Intramuscular Injecting Site of Antiandrogen.
    Hsieh TC; Wu YC; Kao CH; Yen KY; Sun SS
    Clin Nucl Med; 2022 May; 47(5):e401-e402. PubMed ID: 35085174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complementary Role of 18 F-Fluciclovine PET/CT and 18 F-NaF PET/CT in Detecting Prostate Cancer Metastasis.
    Xu F; Liu F; Chen W
    Clin Nucl Med; 2023 Apr; 48(4):330-331. PubMed ID: 36716502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidental 18F-Fluciclovine Uptake in a Warthin Tumor of the Parotid Gland in a Patient Undergoing PET/CT Imaging for Biochemical Recurrent Prostate Cancer.
    Bitar R; Martiniova L; Bell D; Ravizzini G
    Clin Nucl Med; 2020 Apr; 45(4):e208-e210. PubMed ID: 31977491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorine-18-Labeled Fluciclovine PET/CT in Primary and Biochemical Recurrent Prostate Cancer Management.
    Marcus C; Butler P; Bagrodia A; Cole S; Subramaniam RM
    AJR Am J Roentgenol; 2020 Aug; 215(2):267-276. PubMed ID: 32551903
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases.
    Chau A; Gardiner P; Colletti PM; Jadvar H
    Clin Nucl Med; 2018 Jul; 43(7):e226-e231. PubMed ID: 29762238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (
    Bach-Gansmo T; Nanni C; Nieh PT; Zanoni L; Bogsrud TV; Sletten H; Korsan KA; Kieboom J; Tade FI; Odewole O; Chau A; Ward P; Goodman MM; Fanti S; Schuster DM; Willoch F
    J Urol; 2017 Mar; 197(3 Pt 1):676-683. PubMed ID: 27746282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poorly Differentiated Neuroendocrine Tumor With 18F-Fluciclovine Uptake in a Patient With Metastatic Castrate-Resistant Prostate Cancer.
    Abiodun-Ojo OA; Akintayo AA; Harik LR; Bilen M; Halkar RK
    Clin Nucl Med; 2021 May; 46(5):e282-e285. PubMed ID: 33208627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal Stromal Tumor Incidentally Detected on 18F-Fluciclovine PET/CT.
    Raghavan K; Flavell RR; Westphalen AC; Behr SC
    Clin Nucl Med; 2021 Apr; 46(4):345-347. PubMed ID: 33234933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for
    Kim EH; Siegel BA; Teoh EJ; Andriole GL;
    Urol Oncol; 2021 Jun; 39(6):365.e9-365.e16. PubMed ID: 33160848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Clinical Utility of
    Nakamoto R; Harrison C; Song H; Guja KE; Hatami N; Nguyen J; Moradi F; Franc BL; Aparici CM; Davidzon G; Iagaru A
    Mol Imaging Biol; 2021 Aug; 23(4):614-623. PubMed ID: 33469884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate Cancer Imaging with 18F-Fluciclovine.
    Savir-Baruch B; Schuster DM
    PET Clin; 2022 Oct; 17(4):607-620. PubMed ID: 36229104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial Experience with the Radiotracer 18F-Fluciclovine PET/CT in Ovarian Cancer.
    Buehner TM; Liotta M; Potkul RK; Wagner RH; Savir-Baruch B
    Mol Imaging Biol; 2024 Feb; 26(1):45-52. PubMed ID: 36754935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidental Detection of Metastatic Penile Squamous-Cell Carcinoma With Anti-1-Amino-3-F-18-Fluorocyclobutane-1-Carboxylic Acid (
    Bhanvadia RR; Woldu SL; Margulis V; Subramaniam RM; Bagrodia A
    Clin Genitourin Cancer; 2019 Feb; 17(1):e184-e186. PubMed ID: 30454969
    [No Abstract]   [Full Text] [Related]  

  • 37. Oligodendroglioma in 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT.
    Pernthaler B; Nazerani Hooshmand T; Igrec J; Kvaternik H; Aigner RM
    Clin Nucl Med; 2021 Apr; 46(4):e231-e232. PubMed ID: 33086280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-Fluciclovine-Avid Pulmonary Hamartoma.
    Baldeosingh SC; Rowe SP; Greco SC; Paller CJ; Goel R
    Clin Nucl Med; 2021 Nov; 46(11):919-921. PubMed ID: 34582137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated Intravascular Prostate Carcinoma Recurrence Confirmed With 18F-Fluciclovine PET/CT and MRI.
    Agely A; Sharma A; Parent EE; Nawaz A; Jain MK
    Clin Nucl Med; 2020 Jun; 45(6):442-443. PubMed ID: 32332299
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Seierstad T; Hole KH; Tulipan AJ; Strømme H; Lilleby W; Revheim ME; Hernes E
    PET Clin; 2021 Apr; 16(2):167-176. PubMed ID: 33648662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.